Literature DB >> 10525453

Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.

M R Oggioni1, D Medaglini, T Maggi, G Pozzi.   

Abstract

A genetic system for surface display of heterologous proteins has been developed in Streptococcus gordonii, a gram-positive human oral commensal that is naturally competent for genetic transformation. Our approach is based on chromosomal integration downstream from a resident promoter and translational fusion to an M6 protein. Using this strategy a variety of proteins, of different origin and size, were displayed on the cell surface and were shown to be stably expressed both in vitro and in vivo. Animal models of mucosal colonization (oral and vaginal) and intragastric immunization with recombinant S. gordonii were developed and the local and systemic immune responses were studied. Here we report the techniques for the construction of recombinant bacteria, use of animal models, and analysis of the immune response. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525453     DOI: 10.1006/meth.1999.0842

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  8 in total

1.  Bacterial SLH domain proteins are non-covalently anchored to the cell surface via a conserved mechanism involving wall polysaccharide pyruvylation.

Authors:  S Mesnage; T Fontaine; T Mignot; M Delepierre; M Mock; A Fouet
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

2.  In vivo activation of naive CD4+ T cells in nasal mucosa-associated lymphoid tissue following intranasal immunization with recombinant Streptococcus gordonii.

Authors:  Donata Medaglini; Annalisa Ciabattini; Anna Maria Cuppone; Caterina Costa; Susanna Ricci; Massimo Costalonga; Gianni Pozzi
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii.

Authors:  Annalisa Ciabattini; Anna Maria Cuppone; Rita Pulimeno; Francesco Iannelli; Gianni Pozzi; Donata Medaglini
Journal:  Clin Vaccine Immunol       Date:  2006-09

4.  Integrative expression system for delivery of antibody fragments by lactobacilli.

Authors:  M Cruz Martín; Neha Pant; Victor Ladero; Gökçe Günaydin; Kasper Krogh Andersen; Beatriz Alvarez; Noelia Martínez; Miguel A Alvarez; Lennart Hammarström; Harold Marcotte
Journal:  Appl Environ Microbiol       Date:  2011-01-21       Impact factor: 4.792

5.  Expression of a functional single-chain variable-fragment antibody against complement receptor 1 in Streptococcus gordonii.

Authors:  Jennifer B Knight; Scott A Halperin; Kenneth A West; Song F Lee
Journal:  Clin Vaccine Immunol       Date:  2008-04-02

6.  Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordonii.

Authors:  Chiang W Lee; Song F Lee; Scott A Halperin
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

7.  Primary activation of antigen-specific naive CD4+ and CD8+ T cells following intranasal vaccination with recombinant bacteria.

Authors:  Annalisa Ciabattini; Elena Pettini; Peter Andersen; Gianni Pozzi; Donata Medaglini
Journal:  Infect Immun       Date:  2008-10-06       Impact factor: 3.441

8.  Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes.

Authors:  Praveen Mannam; Kevin F Jones; Bruce L Geller
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.